National Capital Consortium Pulmonary Disease and Critical Care Medicine

Topics

• Venous Thromboembolism Diagnosis and Management 80
• Nosocomial Infections in ICU 66
• Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 53
• Obstructive Sleep Apnea Research 26
• Pulmonary Hypertension Research and Treatments 26
• Sepsis Diagnosis and Treatment 26
• Antimicrobial Resistance in Staphylococcus 24
• Mechanical Circulatory Support Devices 24
• Antifungal resistance and susceptibility 23
• Innovations in Medical Education 23
• Pneumonia and Respiratory Infections 22
• Respiratory Support and Mechanisms 22

Most cited

1. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.

   Chest · 2021 · 806 citations · Christopher King, Lisa Moores

2. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

   Circulation · 2026 · 73 citations · Lisa Moores

3. Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK).

   The Lancet. Infectious diseases · 2023 · 267 citations · Andrew Shorr

4. Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline.

   Chest · 2022 · 323 citations · Lisa Moores

5. Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial.

   The Lancet. Infectious diseases · 2021 · 400 citations · Andrew Shorr